Figure 1.
Prognosis analysis for ovarian cancer stage I+II and III+IV based on the expression of genes from the four immune signatures. (A) Table of the association of the expression of the genes composing the four immune signatures with progression free survival (PFS) and overall survival (OS) in stage I and II ovarian cancer and the heatmap that summarized the information contained in the table. (B) Association of the expression of the genes composing the four immune signatures with progression free survival (PFS) and overall survival (OS) in stage III+IV ovarian cancer and heatmap summarizing the information from the table. The tables show the hazard ratio (HR) and the Kaplan-Meier p-value for the individual genes of the four immune signatures. The signatures which predicted favorable outcome are highlighted in green and those which predicted detrimental outcome are highlighted in red. (C) Kaplan-Meier survival plots showing the association between the four immune signatures and OS. The hazard ratio (HR) and the Kaplan-Meier p-value are shown.
